Evolent Health, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 496.2M | 468.7M | 479.5M | 444.3M | 483.6M | 646.5M | 621.4M | 647.1M |
| Cost of Goods Sold | 434.3M | 416.5M | 403.7M | 367.4M | 381.2M | 570.8M | 540.7M | 540.3M |
| Gross Profit | 61.9M | 52.2M | 75.9M | 76.9M | 102.5M | 75.7M | 80.7M | 106.8M |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 72.1M | 61.9M | 75.2M | 74.1M | 104.1M | 94.3M | 97.0M | 99.1M |
| Operating Income | -10.1M | -9.6M | 658K | 2.8M | -1.6M | -18.6M | -16.3M | 7.8M |
| Other Income / Gains | -15.6M | -421.2M | -20.6M | -23.5M | -61.5M | -5.3M | -7.5M | -6.4M |
| Net Income | -26.6M | -429.1M | -20.9M | -19.9M | -64.6M | -22.8M | -23.1M | 1.6M |
| EPS (Diluted) | -0.24 | -3.76 | -0.24 | -0.44 | -0.63 | -0.27 | -0.27 | -0.056 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.125 | 0.111 | 0.158 | 0.173 | 0.212 | 0.117 | 0.13 | 0.165 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 78.4M | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 72.1M | 61.9M | 75.2M | 74.1M | 78.4M | 47.0M | 67.1M | 69.2M |
| Other Expenses | 0 | 0 | 0 | 0 | 25.7M | 47.3M | 29.9M | 29.9M |
| Cost And Expenses | 506.4M | 478.4M | 478.9M | 441.5M | 485.3M | 665.1M | 637.7M | 639.4M |
| Interest Income | 1.0M | 868K | 964K | 1.1M | 1.3M | 830K | 794K | 1.4M |
| Interest Expense | 16.9M | 19.0M | 16.5M | 11.6M | 10.4M | 6.7M | 6.0M | 6.0M |
| Depreciation And Amortization | 22.5M | 45.0M | 26.8M | 24.4M | 24.1M | 30.5M | 29.7M | 29.9M |
| Ebitda | 13.6M | -366.8M | 23.3M | 15.3M | -28.7M | 13.3M | 12.0M | 36.3M |
| Ebitdaratio | 0.027 | -0.782 | 0.049 | 0.034 | -0.059 | 0.021 | 0.019 | 0.056 |
| Operating Income Ratio | -0.02 | -0.021 | 0.001 | 0.006 | -0.003 | -0.029 | -0.026 | 0.012 |
| Income Before Tax | -25.7M | -430.8M | -20.0M | -20.7M | -63.1M | -23.9M | -23.8M | 1.4M |
| Income Before Tax Ratio | -0.052 | -0.919 | -0.042 | -0.047 | -0.131 | -0.037 | -0.038 | 0.002 |
| Income Tax Expense | 910K | -1.7M | 906K | -825K | 1.5M | -1.1M | -619K | -238K |
| Net Income Ratio | -0.054 | -0.916 | -0.044 | -0.045 | -0.134 | -0.035 | -0.037 | 0.002 |
| Epsdiluted | -0.24 | -3.76 | -0.24 | -0.44 | -0.63 | -0.27 | -0.27 | -0.056 |
| Weighted Average Shs Out | 111.9M | 114.2M | 114.1M | 115.9M | 115.3M | 115.0M | 114.9M | 114.7M |
| Weighted Average Shs Out Dil | 111.9M | 114.2M | 114.1M | 115.9M | 115.3M | 115.0M | 114.9M | 114.7M |